vs

Side-by-side financial comparison of Cherry Hill Mortgage Investment Corp (CHMI) and Lakeside Holding Ltd (LSH). Click either name above to swap in a different company.

Cherry Hill Mortgage Investment Corp is the larger business by last-quarter revenue ($11.8M vs $7.0M, roughly 1.7× Lakeside Holding Ltd). On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs -37.2%).

Cherry Hill Mortgage Investment Corp is a U.S.-headquartered real estate finance firm focused on acquiring, investing in and managing residential mortgage-related assets. Its core holdings include agency mortgage-backed securities, residential loans and mortgage servicing rights, operating primarily in the U.S. domestic housing finance market.

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

CHMI vs LSH — Head-to-Head

Bigger by revenue
CHMI
CHMI
1.7× larger
CHMI
$11.8M
$7.0M
LSH
Growing faster (revenue YoY)
LSH
LSH
+132.2% gap
LSH
95.0%
-37.2%
CHMI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CHMI
CHMI
LSH
LSH
Revenue
$11.8M
$7.0M
Net Profit
$-1.6M
Gross Margin
78.9%
27.2%
Operating Margin
72.1%
-21.3%
Net Margin
-22.6%
Revenue YoY
-37.2%
95.0%
Net Profit YoY
18.7%
EPS (diluted)
$0.18
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHMI
CHMI
LSH
LSH
Q4 25
$11.8M
$7.0M
Q3 25
$8.6M
$6.1M
Q2 25
$6.0M
$6.3M
Q1 25
$-3.0M
$3.8M
Q4 24
$18.7M
$3.6M
Q3 24
$-7.1M
$4.1M
Q2 24
$6.6M
Q1 24
$16.3M
Net Profit
CHMI
CHMI
LSH
LSH
Q4 25
$-1.6M
Q3 25
$4.5M
$-1.4M
Q2 25
$1.6M
$-893.1K
Q1 25
$-7.0M
$-1.1M
Q4 24
$-1.9M
Q3 24
$-12.4M
$-1.3M
Q2 24
$784.0K
Q1 24
$12.1M
Gross Margin
CHMI
CHMI
LSH
LSH
Q4 25
78.9%
27.2%
Q3 25
73.2%
18.2%
Q2 25
67.7%
26.7%
Q1 25
183.4%
18.8%
Q4 24
83.3%
-1.2%
Q3 24
145.3%
12.8%
Q2 24
47.5%
Q1 24
83.9%
Operating Margin
CHMI
CHMI
LSH
LSH
Q4 25
72.1%
-21.3%
Q3 25
56.0%
-20.8%
Q2 25
44.4%
-8.9%
Q1 25
223.6%
-28.2%
Q4 24
76.2%
-55.6%
Q3 24
171.8%
-32.5%
Q2 24
22.0%
Q1 24
78.0%
Net Margin
CHMI
CHMI
LSH
LSH
Q4 25
-22.6%
Q3 25
52.7%
-22.2%
Q2 25
25.9%
-14.2%
Q1 25
229.2%
-28.2%
Q4 24
-54.1%
Q3 24
175.8%
-32.7%
Q2 24
11.9%
Q1 24
73.7%
EPS (diluted)
CHMI
CHMI
LSH
LSH
Q4 25
$0.18
$-0.08
Q3 25
$0.05
$-0.09
Q2 25
$-0.03
$-0.11
Q1 25
$-0.29
$-0.14
Q4 24
$0.30
$-0.26
Q3 24
$-0.49
$-0.18
Q2 24
$-0.06
Q1 24
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHMI
CHMI
LSH
LSH
Cash + ST InvestmentsLiquidity on hand
$54.9M
$1.6M
Total DebtLower is stronger
$146.3M
$2.4M
Stockholders' EquityBook value
$236.0M
$12.2M
Total Assets
$1.5B
$24.3M
Debt / EquityLower = less leverage
0.62×
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHMI
CHMI
LSH
LSH
Q4 25
$54.9M
$1.6M
Q3 25
$55.4M
$4.5M
Q2 25
$58.0M
$5.0M
Q1 25
$47.3M
$1.5M
Q4 24
$46.3M
$1.1M
Q3 24
$50.2M
$2.7M
Q2 24
$52.4M
Q1 24
$47.5M
Total Debt
CHMI
CHMI
LSH
LSH
Q4 25
$146.3M
$2.4M
Q3 25
$148.0M
$2.4M
Q2 25
$150.1M
$1.4M
Q1 25
$150.1M
$774.2K
Q4 24
$152.1M
$784.8K
Q3 24
$151.8M
$589.9K
Q2 24
$160.5M
Q1 24
$167.5M
Stockholders' Equity
CHMI
CHMI
LSH
LSH
Q4 25
$236.0M
$12.2M
Q3 25
$233.1M
$7.0M
Q2 25
$229.9M
$2.8M
Q1 25
$226.6M
$749.8K
Q4 24
$230.3M
$1.6M
Q3 24
$236.7M
$3.6M
Q2 24
$234.5M
Q1 24
$247.0M
Total Assets
CHMI
CHMI
LSH
LSH
Q4 25
$1.5B
$24.3M
Q3 25
$1.5B
$18.6M
Q2 25
$1.5B
$14.4M
Q1 25
$1.4B
$9.9M
Q4 24
$1.5B
$9.8M
Q3 24
$1.6B
$10.8M
Q2 24
$1.4B
Q1 24
$1.4B
Debt / Equity
CHMI
CHMI
LSH
LSH
Q4 25
0.62×
0.20×
Q3 25
0.63×
0.35×
Q2 25
0.65×
0.48×
Q1 25
0.66×
1.03×
Q4 24
0.66×
0.48×
Q3 24
0.64×
0.16×
Q2 24
0.68×
Q1 24
0.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHMI
CHMI
LSH
LSH
Operating Cash FlowLast quarter
$19.1M
$-453.5K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHMI
CHMI
LSH
LSH
Q4 25
$19.1M
$-453.5K
Q3 25
$-2.4M
$-4.0M
Q2 25
$12.5M
$-483.7K
Q1 25
$682.0K
$-238.3K
Q4 24
$-4.7M
$-530.2K
Q3 24
$4.4M
$-1.4M
Q2 24
$4.1M
Q1 24
$-19.1M
Free Cash Flow
CHMI
CHMI
LSH
LSH
Q4 25
Q3 25
Q2 25
$-497.4K
Q1 25
Q4 24
$-560.5K
Q3 24
$-1.4M
Q2 24
Q1 24
FCF Margin
CHMI
CHMI
LSH
LSH
Q4 25
Q3 25
Q2 25
-7.9%
Q1 25
Q4 24
-15.6%
Q3 24
-34.5%
Q2 24
Q1 24
Capex Intensity
CHMI
CHMI
LSH
LSH
Q4 25
Q3 25
Q2 25
0.2%
Q1 25
0.0%
Q4 24
0.8%
Q3 24
0.1%
Q2 24
Q1 24
Cash Conversion
CHMI
CHMI
LSH
LSH
Q4 25
Q3 25
-0.53×
Q2 25
7.98×
Q1 25
Q4 24
Q3 24
Q2 24
5.18×
Q1 24
-1.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHMI
CHMI

Segment breakdown not available.

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

Related Comparisons